Previously, we demonstrated that 17β-estradiol (E2) accelerates the growth of ERα-negative tumors (B16K1 melanoma, LLC lung and 4T1 mammary cancer cells) through the development of a vascular supply by activating stromal ERα that normalizes tumor angiogenesis 10. The gene discussed is ESR1; the disease is melanoma.